Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology

[1]  K. Imahori,et al.  Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Imahori,et al.  Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites , 1995, Neuroscience Letters.

[3]  K. Imahori,et al.  Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria. , 1995, Journal of biochemistry.

[4]  K. Imahori,et al.  Amyloid β peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3β in rat hippocampal neurons , 1995, Neuroscience Letters.

[5]  M. Mercken,et al.  Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.

[6]  K. Imahori,et al.  Involvement of τ Protein Kinase I in Paired Helical Filament‐Like Phosphorylation of the Juvenile τ in Rat Brain , 1995 .

[7]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[8]  M. Goedert,et al.  Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.

[9]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[10]  T B Shea,et al.  Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[11]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[12]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[13]  J. Woodgett,et al.  PHF‐tau from Alzheimer's brain comprises four species on SDS‐PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase‐3β , 1994, FEBS letters.

[14]  J. Woodgett.  Regulation and functions of the glycogen synthase kinase-3 subfamily. , 1994, Seminars in cancer biology.

[15]  K. Imahori,et al.  Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat Brain , 1994 .

[16]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[17]  A Hirano,et al.  Hirano bodies and related neuronal inclusions , 1994, Neuropathology and applied neurobiology.

[18]  E. Mandelkow,et al.  Tau as a marker for Alzheimer's disease. , 1993, Trends in biochemical sciences.

[19]  R. Cote,et al.  Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  M. Goedert.  Tau protein and the neurofibrillary pathology of Alzheimer's disease , 1993, Trends in Neurosciences.

[21]  K. Imahori,et al.  Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[23]  S. Yang,et al.  Cyclic modulation of cytoskeleton assembly-disassembly by the ATP.Mg-dependent protein phosphatase activator (kinase FA). , 1993, Biochemical and biophysical research communications.

[24]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Imahori,et al.  τ Protein Kinase II Is Involved in the Regulation of the Normal Phosphorylation State of τ Protein , 1993 .

[26]  G. Drewes,et al.  Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau , 1992, FEBS letters.

[27]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.

[28]  K. Imahori,et al.  Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments , 1992, Neuroscience Letters.

[29]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[30]  K. Imahori,et al.  Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. , 1992, The Journal of biological chemistry.

[31]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[32]  K. Ishiguro,et al.  Improved protective groups for phosphate of o-phosphoserine useful for the solid-phase peptide synthesis , 1991 .

[33]  K. Imahori,et al.  A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope , 1991, Neuroscience Letters.

[34]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  T. Iwaki,et al.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[36]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[37]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[38]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[39]  V. Lee,et al.  Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[40]  H. Tung,et al.  Purification and characterization of protein phosphatase 1I activating kinase from bovine brain cytosolic and particulate fractions. , 1989, The Journal of biological chemistry.

[41]  M. L. Schmidt,et al.  Distribution of tau proteins in the normal human central and peripheral nervous system. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  J. Wood,et al.  Differential sensitivity of the microtubule-associated protein, tau, in Alzheimer's disease tissue to formalin fixation. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  K. Imahori,et al.  A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau. , 1988, Journal of biochemistry.

[44]  B. Hyman,et al.  A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50 , 1988, Brain Research.

[45]  A. Hirano,et al.  A COMPARATIVE STUDY OF MODIFIED BIELSCHOWSKY, BODIAN AND THIOFLAVIN S STAINS ON ALZHEIMER'S NEUROFIBRILLARY TANGLES , 1986, Neuropathology and applied neurobiology.

[46]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[47]  S. Sorbi,et al.  Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain , 1983, Annals of neurology.

[48]  E. Perry,et al.  Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase , 1980, Neuroscience Letters.

[49]  B. Tomlinson,et al.  Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease , 1977, Journal of the Neurological Sciences.

[50]  L. Kurland,et al.  Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. , 1966, Archives of neurology.

[51]  R. Cote,et al.  Antigen Retrieval Technique: A Novel Approach to Immunohistochemistry on Routinely Processed Tissue Sections , 1996 .

[52]  A. Takashima.  Tau protein I is essential for amyloid β-protein iduced neurotoxicity , 1993 .

[53]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .